Isaac Che Ngang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isaac Che Ngang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Vaishnavi Mamillapalle
Affiliation Stanford University, Stanford, California, United States of America
3 shared publications - Akila Anandarajah
Vanderbilt University School of Medicine, Nashville, Tennessee, USA
2 shared publications - Beryne Odeny
Washington University St Louis, USA
2 shared publications Mariam Balogun
Affiliation Department of Medicine, Washington University, St. Louis, Missouri, United States of America
2 shared publications- Aimee S. James
Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
1 shared publication Amr S. Soliman
CUNY: City University of New York
1 shared publication
Latest Publications
- Open Access
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (4) , e0006046
An emerging TIMER-2C framework for addressing barriers to research culture and productivity among local healthcare providers in the Middle East and sub-Saharan Africa: A qualitative study and modified Delphi approach
Contributions from healthcare professionals in the Middle East and North Africa (MENA) and sub-Saharan Africa (SSA) to global health research remain disproportionately low. We conceptualized the TIMER-2C framework to capture the multi-level barriers and facilitators shaping research productivity among local healthcare professionals in MENA and SSA. We conducted qualitative interviews using a modified Delphi approach comprising two rounds to: 1) identify barriers and facilitators, and 2) establish consensus on the most prominent factors influencing research productivity. We purposively sampled 17 participants from Jordan, Qatar, Egypt, Lebanon, North Sudan, South Sudan, Nigeria, Ghana, Kenya, Uganda, Ethiopia, South Africa and India. Interview guides were grounded in theoretical frameworks. Transcripts were analyzed for barriers, facilitators, and recommendations for increasing research output. Barriers and facilitators to research productivity occurred at individual, institutional, national, and global levels. Key barriers included limited time, funding, mentorship, and research training; institutional prioritization of clinical and teaching duties over research; lack of national investment and supportive policies; and global challenges in funding, publishing, and collaboration. Facilitators included personal motivation, protected time, access to training and mentorship, institutional support for research, national funding strategies, and meaningful global partnerships that value local contributions. We identified six themes and one overarching theme from which we coined the TIMER-2C framework: 1) T ime, 2) I nstability, Interest & Infrastructure, 3) M oney & Resources, 4) E xpertise & Experience, 5) R ecognition, and 6) constructive C ollaboration, together fostering a positive research C ulture (2C). Research culture emerged as an overarching influence on research contributions. We unveil an emerging framework, the TIMER-2C , that depicts relationships among multilevel factors shaping research productivity and offers a useful tool to guide and evaluate local capacity-building strategies. We recommend further application of this framework to guide the design, implementation and evaluation of multi-pronged strategies to enhance research contributions from MENA, SSA, and similar contexts.
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (4) , e0006046
Open AccessAn emerging TIMER-2C framework for addressing barriers to research culture and productivity among local healthcare providers in the Middle East and sub-Saharan Africa: A qualitative study and modified Delphi approach
Contributions from healthcare professionals in the Middle East and North Africa (MENA) and sub-Saharan Africa (SSA) to global health research remain disproportionately low. We conceptualized the TIMER-2C framework to capture the multi-level barriers and facilitators shaping research productivity among local healthcare professionals in MENA and SSA. We conducted qualitative interviews using a modified Delphi approach comprising two rounds to: 1) identify barriers and facilitators, and 2) establish consensus on the most prominent factors influencing research productivity. We purposively sampled 17 participants from Jordan, Qatar, Egypt, Lebanon, North Sudan, South Sudan, Nigeria, Ghana, Kenya, Uganda, Ethiopia, South Africa and India. Interview guides were grounded in theoretical frameworks. Transcripts were analyzed for barriers, facilitators, and recommendations for increasing research output. Barriers and facilitators to research productivity occurred at individual, institutional, national, and global levels. Key barriers included limited time, funding, mentorship, and research training; institutional prioritization of clinical and teaching duties over research; lack of national investment and supportive policies; and global challenges in funding, publishing, and collaboration. Facilitators included personal motivation, protected time, access to training and mentorship, institutional support for research, national funding strategies, and meaningful global partnerships that value local contributions. We identified six themes and one overarching theme from which we coined the TIMER-2C framework: 1) T ime, 2) I nstability, Interest & Infrastructure, 3) M oney & Resources, 4) E xpertise & Experience, 5) R ecognition, and 6) constructive C ollaboration, together fostering a positive research C ulture (2C). Research culture emerged as an overarching influence on research contributions. We unveil an emerging framework, the TIMER-2C , that depicts relationships among multilevel factors shaping research productivity and offers a useful tool to guide and evaluate local capacity-building strategies. We recommend further application of this framework to guide the design, implementation and evaluation of multi-pronged strategies to enhance research contributions from MENA, SSA, and similar contexts.
- Open Access
Cardiovascular disease risk and Lung cancer screening for Early Assessment of Risk (project CLEAR) in Missouri: A protocol for a mixed methods study
Background Lung cancer and atherosclerotic cardiovascular disease (ASCVD) are leading causes of mortality in the United States, sharing common risk factors like smoking and age. Preventive care for these conditions is often siloed, leading to missed opportunities to prevent ASCVD-related mortality in lung cancer screening (LCS) patients. In various trial settings, patients undergoing LCS were more likely to die from ASCVD than from cancer; however, less than half of eligible patients got statin prescription. This study aims to understand the degree to which ASCVD risk assessment and prevention is done in routine “real-world” clinical settings providing LCS in Missouri. Our objectives are to determine the prevalence of statin eligibility, statin prescription and explore factors, disparities and barriers to statin therapy in people undergoing LCS. Methods A parallel convergent mixed-methods design will be used. Quantitative data from people undergoing LCS at Barnes-Jewish Healthcare System will be extracted from Epic electronic medical records (EMR) from January 2022-December 2023, capturing demographics, socioeconomic factors, and clinical data including ASCVD risk factors and statin use. We anticipate gathering about records for approximately 8,000 patients. Qualitative data will be gathered from in-depth interviews with up to 15 healthcare providers to identify barriers, facilitators and recommendations for enhancing statin therapy in people undergoing LCS. Discussion The risk of mortality is drastically heightened in people undergoing LCS who are not receiving statin therapy, and thus there is an urgent need to identify those who are eligible but not receiving ASCVD prevention. Promoting ASCVD risk assessment and prevention in LCS programs has the potential to mitigate the dual burden of ASCVD and lung cancer in high-risk populations who smoke cigarettes. This study will demonstrate the extent of the gap in statin therapy among LCS and provide insights into disparities, barriers and recommendations for integrating ASCVD risk assessment and prevention with LCS. Conclusion This study will provide real-world baseline data on statin therapy among people undergoing LCS in Missouri, and will highlight disparities, barriers and recommendations for integrating ASCVD prevention in LCS.
Open AccessCardiovascular disease risk and Lung cancer screening for Early Assessment of Risk (project CLEAR) in Missouri: A protocol for a mixed methods study
Background Lung cancer and atherosclerotic cardiovascular disease (ASCVD) are leading causes of mortality in the United States, sharing common risk factors like smoking and age. Preventive care for these conditions is often siloed, leading to missed opportunities to prevent ASCVD-related mortality in lung cancer screening (LCS) patients. In various trial settings, patients undergoing LCS were more likely to die from ASCVD than from cancer; however, less than half of eligible patients got statin prescription. This study aims to understand the degree to which ASCVD risk assessment and prevention is done in routine “real-world” clinical settings providing LCS in Missouri. Our objectives are to determine the prevalence of statin eligibility, statin prescription and explore factors, disparities and barriers to statin therapy in people undergoing LCS. Methods A parallel convergent mixed-methods design will be used. Quantitative data from people undergoing LCS at Barnes-Jewish Healthcare System will be extracted from Epic electronic medical records (EMR) from January 2022-December 2023, capturing demographics, socioeconomic factors, and clinical data including ASCVD risk factors and statin use. We anticipate gathering about records for approximately 8,000 patients. Qualitative data will be gathered from in-depth interviews with up to 15 healthcare providers to identify barriers, facilitators and recommendations for enhancing statin therapy in people undergoing LCS. Discussion The risk of mortality is drastically heightened in people undergoing LCS who are not receiving statin therapy, and thus there is an urgent need to identify those who are eligible but not receiving ASCVD prevention. Promoting ASCVD risk assessment and prevention in LCS programs has the potential to mitigate the dual burden of ASCVD and lung cancer in high-risk populations who smoke cigarettes. This study will demonstrate the extent of the gap in statin therapy among LCS and provide insights into disparities, barriers and recommendations for integrating ASCVD risk assessment and prevention with LCS. Conclusion This study will provide real-world baseline data on statin therapy among people undergoing LCS in Missouri, and will highlight disparities, barriers and recommendations for integrating ASCVD prevention in LCS.
- Open Access
Depression and Complicated Grief Among Parents of Pediatric Cancer Patients in Cameroon: Implications for Global Health in Low-income Countries
Background and Objectives: Bereaved parents of pediatric cancer patients frequently experience severe grief and psychological distress, but studies on the prevalence of major depressive disorder (MDD) and complicated grief (CG) among this population in Cameroon are lacking. This study aimed to determine the prevalence of MDD and CG among bereaved parents of deceased pediatric cancer patients treated at Mbingo Baptist Hospital Cameroon, and to identify predictors of these mental health outcomes. Methods: This cross-sectional study included parents of deceased pediatric cancer patients treated at Mbingo Baptist Hospital between January 2015 and January 2022. Multivariate logistic regression identified predictors of MDD and CG as adjusted odds ratios (AOR) with 95% confidence intervals (CIs). Results: The prevalence of CG in this population was 86%, while 66.7% of the study subjects screened positive for MDD. Significant predictors of MDD included age [OR 1.091, p=0.018], financial hardship [OR 9.47, p=0.014], accurate knowledge of the child’s prognosis [OR 0.268, p=0.046], perceived social support [(poor social support OR 6.402, P=0.039), (moderate social support OR 8.556, p=0.045)], and coping capacity [medium resilient copers OR 7.874, p=0.027]. Predictors of CG included age [OR 1.157, p=0.032], financial hardship [OR 11.501, p=0.04], years passed since child loss [1-2 years OR 4.634, p=0.049], and coping capacity [(low resilient copers OR 14.011, p<0.01), (medium resilient copers OR 19.023, p<0.01)]. Conclusions: The study revealed high prevalence of MDD and CG among bereaved parents of pediatric cancer patients in Cameroon. Financial difficulty, social support, and coping capacity had substantial impact on parental mental health outcomes in this population. Personalized mental health support services into pediatric oncology care is critical for assisting bereaved families and encouraging resilience in the face of loss may improve health and wellbeing of the families. The study may have implications for global mental health in similar low-income countries.
Open AccessDepression and Complicated Grief Among Parents of Pediatric Cancer Patients in Cameroon: Implications for Global Health in Low-income Countries
Background and Objectives: Bereaved parents of pediatric cancer patients frequently experience severe grief and psychological distress, but studies on the prevalence of major depressive disorder (MDD) and complicated grief (CG) among this population in Cameroon are lacking. This study aimed to determine the prevalence of MDD and CG among bereaved parents of deceased pediatric cancer patients treated at Mbingo Baptist Hospital Cameroon, and to identify predictors of these mental health outcomes. Methods: This cross-sectional study included parents of deceased pediatric cancer patients treated at Mbingo Baptist Hospital between January 2015 and January 2022. Multivariate logistic regression identified predictors of MDD and CG as adjusted odds ratios (AOR) with 95% confidence intervals (CIs). Results: The prevalence of CG in this population was 86%, while 66.7% of the study subjects screened positive for MDD. Significant predictors of MDD included age [OR 1.091, p=0.018], financial hardship [OR 9.47, p=0.014], accurate knowledge of the child’s prognosis [OR 0.268, p=0.046], perceived social support [(poor social support OR 6.402, P=0.039), (moderate social support OR 8.556, p=0.045)], and coping capacity [medium resilient copers OR 7.874, p=0.027]. Predictors of CG included age [OR 1.157, p=0.032], financial hardship [OR 11.501, p=0.04], years passed since child loss [1-2 years OR 4.634, p=0.049], and coping capacity [(low resilient copers OR 14.011, p<0.01), (medium resilient copers OR 19.023, p<0.01)]. Conclusions: The study revealed high prevalence of MDD and CG among bereaved parents of pediatric cancer patients in Cameroon. Financial difficulty, social support, and coping capacity had substantial impact on parental mental health outcomes in this population. Personalized mental health support services into pediatric oncology care is critical for assisting bereaved families and encouraging resilience in the face of loss may improve health and wellbeing of the families. The study may have implications for global mental health in similar low-income countries.